[Neuroendocrine carcinoma of the digestive tract: a literature review]

Rev Med Interne. 2013 Nov;34(11):700-5. doi: 10.1016/j.revmed.2013.02.013. Epub 2013 Jul 18.
[Article in French]

Abstract

Neuroendocrine carcinoma is a rare and agressive malignant tumor, mainly developing at the expense of the respiratory and of the digestive tract. Among the digestive tract, appendix, small bowel, and pancreas are the preferential sites of involvement, other locations have been more rarely reported. Neuroendocrine digestive tumors may present with various symptoms in relationship with their localization and a complex pathophysiology. Diagnosis is often made at an advanced stage, explaining partly the bad prognosis of these tumors. The optimal management of digestive neuroendocrine tumors is rendered difficult by their rarity and by a low number of randomized trials. We review the literature regarding epidemiologic and prognostic features of these rare tumors, their diagnostic and therapeutic care. Potential complications are also discussed.

Keywords: Appareil digestif; Carcinome neuro-endocrine; Chemotherapy; Chimiothérapie; Digestive tract; Neuroendocrine carcinoma.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Carcinoma, Neuroendocrine* / diagnosis
  • Carcinoma, Neuroendocrine* / epidemiology
  • Carcinoma, Neuroendocrine* / pathology
  • Carcinoma, Neuroendocrine* / therapy
  • Diagnostic Techniques, Digestive System
  • Digestive System Neoplasms* / diagnosis
  • Digestive System Neoplasms* / epidemiology
  • Digestive System Neoplasms* / pathology
  • Digestive System Neoplasms* / therapy
  • Humans
  • Liver Neoplasms / secondary
  • Liver Neoplasms / therapy
  • Molecular Targeted Therapy